Literature DB >> 18941641

Baseline glutathione peroxidase activity affects prognosis after acute coronary syndromes.

José Manuel García-Pinilla1, Julio Gálvez, Fernando Cabrera-Bueno, Manuel Jiménez-Navarro, Juan José Gómez-Doblas, Milagros Galisteo, Desiré Camuesco, Carlos de Teresa Galván, Salvador Espinosa-Caliani, Antonio Zarzuelo, Eduardo de Teresa-Galván.   

Abstract

Oxidative stress is associated with atherosclerosis and plaque lesions in experimental in vitro models. Few in vivo studies have examined the association between redox status and the prognosis of acute coronary syndromes.We undertook a prospective, observational study of 137 patients who had been admitted because of an acute coronary syndrome. We determined glutathione peroxidase activity (a marker of systemic antioxidant status) and recorded clinical and angiographic features and cardiovascular events (cardiovascular death, reinfarction, readmission with a new ischemic event, or need for coronary revascularization).The mean age of the patients (78% of whom were men) was 61.7 +/- 10.9 years; 76% were admitted with non-ST-segment-elevation acute coronary syndrome. Left ventricular ejection fraction was normal in 61%. In the 23.4% who experienced cardiovascular events, glutathione peroxidase activity was higher (mean, 2.38 vs 1.76 mU/mg of protein; P < 0.01). Two-year event-free survival was lower in patients whose glutathione peroxidase activity was higher than the 50th percentile (63% vs 82%; P = 0.01). Multivariate analysis showed a direct independent relationship between glutathione peroxidase activity and cardiovascular events (hazard ratio, 3.72; 95% confidence interval, 1.53-9.02; P < 0.01).We conclude that patients who experienced acute coronary syndromes and events during follow-up had higher plasma glutathione peroxidase activity, and that glutathione peroxidase activity was an independent predictor of events during follow-up.

Entities:  

Keywords:  Acute coronary syndromes; arteriosclerosis/etiology; biological markers/blood; glutathione peroxidase; oxidation-reduction; oxidative stress; prognosis

Mesh:

Substances:

Year:  2008        PMID: 18941641      PMCID: PMC2565519     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  28 in total

1.  Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Circulation       Date:  2002-04-30       Impact factor: 29.690

2.  [2002 Update of the Guidelines of the Spanish Society of Cardiology for Unstable Angina/Without ST-Segment Elevation Myocardial Infarction].

Authors:  Lorenzo López Bescós; Fernando Arós Borau; Rosa M Lidón Corbi; Angel Cequier Fillat; Héctor Bueno; Joaquín J Alonso; Isabel Coma Canella; Angel Loma-Osorio; Julián Bayón Fernández; Rafael Masiá Martorell; José Tuñón Fernández; Antonio Fernández-Ortiz; Jaume Marrugat De La Iglesia; Miguel Palencia Pérez
Journal:  Rev Esp Cardiol       Date:  2002-06       Impact factor: 4.753

3.  Vitamin E supplementation and cardiovascular events in high-risk patients.

Authors:  S Yusuf; G Dagenais; J Pogue; J Bosch; P Sleight
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction.

Authors:  Sanjana Dayal; Kara L Brown; Christine J Weydert; Larry W Oberley; Erland Arning; Teodoro Bottiglieri; Frank M Faraci; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

5.  Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease.

Authors:  Cristina Vassalle; Nicoletta Botto; Maria Grazia Andreassi; Sergio Berti; Andrea Biagini
Journal:  Coron Artery Dis       Date:  2003-05       Impact factor: 1.439

6.  Increased plasma glutathione peroxidase activity in patients with acute myocardial infarction.

Authors:  B A Zachara; M Ukleja-Adamowicz; E Nartowicz; J Łecka
Journal:  Med Sci Monit       Date:  2001 May-Jun

7.  Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction.

Authors:  N R Pandey; G Kaur; M Chandra; G G Sanwal; M K Misra
Journal:  Int J Cardiol       Date:  2000-10       Impact factor: 4.164

8.  Cellular glutathione peroxidase deficiency and endothelial dysfunction.

Authors:  Marc A Forgione; Norbert Weiss; Stanley Heydrick; André Cap; Elizabeth S Klings; Charlene Bierl; Robert T Eberhardt; Harrison W Farber; Joseph Loscalzo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

9.  High oxidative stress in patients with stable coronary heart disease.

Authors:  Tanja Weinbrenner; Mercedes Cladellas; Maria Isabel Covas; Montserrat Fitó; Marta Tomás; Mariano Sentí; Jordi Bruguera; Jaume Marrugat
Journal:  Atherosclerosis       Date:  2003-05       Impact factor: 5.162

10.  Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure.

Authors:  Marc A Forgione; Andre Cap; Ronglih Liao; Nicanor I Moldovan; Robert T Eberhardt; Chee Chew Lim; John Jones; Pascal J Goldschmidt-Clermont; Joseph Loscalzo
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  2 in total

1.  Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome.

Authors:  Carlos M Laborde; Laura Mourino-Alvarez; María Posada-Ayala; Gloria Alvarez-Llamas; Manuel Gómez Serranillos-Reus; José Moreu; Fernando Vivanco; Luis R Padial; María G Barderas
Journal:  Metabolomics       Date:  2013-10-26       Impact factor: 4.290

2.  The LDL/HDL ratio predicts long-term risk of coronary revascularization in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: a cohort study.

Authors:  Ruochen Zhang; Yan Fan; Yanbo Xue; Yunfei Feng; Caijuan Dong; Yamei Wang; Puqing Kou; Guoli Li; Aiqun Ma; Tingzhong Wang
Journal:  Braz J Med Biol Res       Date:  2022-02-04       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.